The feasibility and results of a population-based approach to evaluating prostate-specific antigen screening for prostate cancer in men with a raised familial risk-Reference-Cited by-同舟云学术

The feasibility and results of a population-based approach to evaluating prostate-specific antigen screening for prostate cancer in men with a raised familial risk

Published:2006-01-24 Issue:4 Volume:94 Page:499-506
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Melia J, ,Dearnaley D,Moss S,Johns L,Coulson P,Moynihan C,Sweetman J,Parkinson M C,Eeles R,Watson M

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.nature.com/articles/6602925.pdf

Reference25 articles.

1. Bock CH, Peyser PA, Montie JE, Cooney KA (2005) Decreasing age at prostate cancer diagnosis over successive generations in prostate cancer families. Prostate 64: 60–66

2. Bratt O, Damber JE, Emanuelsson M, Kristoffersson U, Lundgren R, Olsson H, Gronberg H (2000) Risk perception, screening practice and interest in genetic testing among unaffected men in families with hereditary prostate cancer. Eur J Cancer 36: 235–241

3. Carter BS, Bova GS, Beaty TH, Steinberg GD, Childs B, Isaacs WB, Walsh PC (1993) Hereditary prostate cancer: epidemiologic and clinical features. J Urol 150: 797–802

4. Donovan J, Mills N, Smith M, Brindle L, Jacoby A, Peters T, Frankel S, Neal D, Hamdy F (2002) Improving design and conduct of randomised trials by embedding them in qualitative research: ProtecT (prostate testing for cancer and treatment) study. BMJ 325: 766–770

5. Edwards SM, Kote-Jarai Z, Meitz J, Hamoudi R, Hope O, Osin P, Jackson R, Southgate C, Singh R, Falconer A, Dearnaley DP, Ardern-Jones A, Murkin A, Dowe A, Kelly J, Williams S, Oram R, Stevens M, Teare DM, Ponder BA, Gayther SA, Easton DF, Eeles RA, Cancer Research UK/Bristish Prostate Group UK Familial Prostate Cancer Study Collaborators, British Association of Urological Surgeons Section of Oncology (2003) Two percent of men with early-onset prostate cancer harbor germline mutations in the BRCA2 gene. Am J Hum Genet 72: 1–12

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Détection précoce du cancer de la prostate chez des apparentés de premier degré au Sénégal;African Journal of Urology;2015-12

2. Targeted prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects aggressive prostate cancer: preliminary analysis of the results of the IMPACT study;BJU International;2010-09-14

3. Prostate Cancer Early Detection Program Recruitment Methods and Show Rates in Men at High Risk;Journal of Urology;2009-11

4. Watching for prostate cancer;Independent Nurse;2006-03

5. Feasibility of familial PSA screening: psychosocial issues and screening adherence;British Journal of Cancer;2006-01-24